mRNA is central to modern therapeutics like vaccines. But the development of mRNA therapeutics requires the robust assessment of critical quality attributes (CQAs), including purity and integrity, to ...

OXFORD, United Kingdom, March 18, 2026 (GLOBE NEWSWIRE)-- Refeyn, developer of pioneering mass photometry technology, announces the launch of MyMass™ mass photometer (MyMassMP), a compact instrument ...

To produce adeno-associated virus (AAV) therapeutics, researchers and technicians must monitor a range of critical quality attributes (CQAs). Currently, scientists use techniques such as analytical ...

A new addition to the mRNA analytics toolbox enables fast, accurate, and easy-to-use sample analysis while keeping RNA molecules in their native state. Producing messenger RNA (mRNA)-based ...

As lentiviral vector (LVV) programs advance toward larger clinical trials and commercialization, manufacturing platforms and analytical strategies must evolve together. In this joint webinar, Minaris ...

The MarketWatch News Department was not involved in the creation of this content. OXFORD, United Kingdom, March 18, 2026 (GLOBE NEWSWIRE) -- Refeyn, developer of pioneering mass photometry technology, ...

Compact, all-in-one mass photometer helps researchers verify sample quality before proceeding to cryo-EM, native MS, BLI, SPR, and other costly experiments OXFORD, United Kingdom, March 18, 2026 ...

OXFORD, United Kingdom, March 18, 2026 (GLOBE NEWSWIRE) -- Refeyn, developer of pioneering mass photometry technology, announces the launch of MyMass™ mass photometer (MyMassMP), a compact instrument ...

Compact, all-in-one mass photometer helps researchers verify sample quality before proceeding to cryo-EM, native MS, BLI, SPR, and other costly experiments OXFORD, United Kingdom, March 18, 2026 ...